# OnCo record paper-hassan-j-clin-oncol (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-hassan-j-clin-oncol/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-hassan-j-clin-oncol" ;
  schema:name "First-in-Human, Multicenter, Phase I Dose-Escalation and Expansion Study of Anti-Mesothelin Antibody-Drug Conjugate Anetumab Ravtansine in Advanced or Metastatic Solid Tumors"@en ;
  schema:description "Paper cited by one treatment page, indexed on Europe PMC as PubMed record 32213105 and published in Journal of Clinical Oncology; the citing page links this DOI, which is how the record was matched."@en ;
  schema:url <https://onco.cc/key-papers/paper-hassan-j-clin-oncol/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/jco.19.02085>, <https://pubmed.ncbi.nlm.nih.gov/32213105/>, <https://europepmc.org/article/MED/32213105> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1200/jco.19.02085> ;
  schema:datePublished "2020"^^xsd:gYear ;
  schema:author "Hassan R, Blumenschein GR, Moore KN, et al." ;
  onco:related <https://onco.cc/drugs/anetumab-ravtansine/> ;
  onco:journals <https://onco.cc/journals/jco/> .